Gut–brain axis as a pathological and therapeutic target for neurodegenerative disorders

ARL Toledo, GR Monroy, FE Salazar, JY Lee… - International journal of …, 2022 - mdpi.com
Human lifestyle and dietary behaviors contribute to disease onset and progression.
Neurodegenerative diseases (NDDs), considered multifactorial disorders, have been …

The brain–gut–bone axis in neurodegenerative diseases: insights, challenges, and future prospects

R Li, Z Miao, Y Liu, X Chen, H Wang, J Su… - Advanced …, 2024 - Wiley Online Library
Neurodegenerative diseases are global health challenges characterized by the progressive
degeneration of nerve cells, leading to cognitive and motor impairments. The brain–gut …

[HTML][HTML] Intestinal permeability, Dysbiosis, inflammation and enteric glia cells: the intestinal etiology of Parkinson's disease

H Yang, S Li, W Le - Aging and disease, 2022 - ncbi.nlm.nih.gov
The scientific and medical communities are becoming more aware of the substantial
relationship between the function of the central nervous system (CNS) and the state of the …

Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability

B Wei, Y Zhao, Y Cheng, C Huang, F Zhang - Immunity & Ageing, 2024 - Springer
Abstract Parkinson's disease (PD), a neurodegenerative disorder with an unknown etiology,
is primarily characterized by the degeneration of dopamine (DA) neurons. The prevalence of …

Effect of berberine hydrochloride on the diversity of intestinal flora in Parkinson's disease patients

J Li, P Meng, J Zhang, M He - Contrast media & molecular …, 2022 - Wiley Online Library
This study aimed to investigate the effect of berberine hydrochloride on the diversity of
intestinal flora in patients with Parkinson's disease (PD). Prospectively selected 68 PD …

Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta‐analysis

S Lu, H Jiang, Y Shi - Acta Neurologica Scandinavica, 2022 - Wiley Online Library
Background Growing evidence suggests that irritable bowel syndrome (IBS) and Parkinson's
disease (PD) share similar pathological mechanisms and risk factors. Methods We …

Personalized assessment of insomnia and sleep quality in patients with Parkinson's disease

Ş Diaconu, C Falup-Pecurariu - Journal of Personalized Medicine, 2022 - mdpi.com
Sleep disturbances are more common in patients with Parkinson's disease (PD) than in the
general population and are considered one of the most troublesome symptoms by these …

Lutein and the Underlying Neuroprotective Promise against Neurodegenerative Diseases

S Iyer, I Bhat… - Molecular Nutrition & Food …, 2024 - Wiley Online Library
Alzheimer's disease (AD) and Parkinson's diseases (PD) are the two most common
progressive neurodegenerative diseases with limited knowledge on their cause and …

Effectiveness of Continuous Dopaminergic Therapies in Parkinson's Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics

A Demailly, C Moreau, D Devos - Journal of Parkinson's …, 2024 - content.iospress.com
Background: Parkinson's disease (PD) is characterized by striatal dopamine deficiency.
Since dopamine cannot cross the digestive and blood-brain barriers, its precursor, levodopa …

The missing piece of the puzzle–The key role of the dietitian in the management of Parkinson's disease

R Flanagan, C Rusch, FE Lithander… - Parkinsonism & Related …, 2024 - Elsevier
The current paradigm for the multidisciplinary management of Parkinson's Disease (PD)
does not include regular nutritional assessment despite research showing that 90% of …